Literature DB >> 10602720

Aminoglycoside resistance in Mycobacterium kansasii, Mycobacterium avium-M. intracellulare, and Mycobacterium fortuitum: are aminoglycoside-modifying enzymes responsible?

I I Ho1, C Y Chan, A F Cheng.   

Abstract

Aminoglycoside acetyltransferase was detected in Mycobacterium kansasii and M. fortuitum but not in M. avium-M. intracellulare when they were screened by a radioassay. Aminoglycoside phosphotransferase and nucleotidyltransferase activities were absent from all three species tested. Acetyltransferases from both M. kansasii and M. fortuitum displayed relatively high K(m)s, all at the millimolar level, for substrates including tobramycin, neomycin, and kanamycin A. The K(m) of each substrate was well above the corresponding maximum achievable level in serum. The low affinities of these enzymes for their substrates suggested that drug modification in vivo was very unlikely. Among the various substrates tested, no apparent positive correlation was found between substrate affinity and resistance level. The presence of aminoglycoside-modifying enzymes in these mycobacterial species was therefore not shown to confer resistance to aminoglycosides.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10602720      PMCID: PMC89625          DOI: 10.1128/AAC.44.1.39-42.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

Review 1.  The crisis in antibiotic resistance.

Authors:  H C Neu
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

Review 2.  Mechanisms of antibiotic resistance in bacteria.

Authors:  R Benveniste; J Davies
Journal:  Annu Rev Biochem       Date:  1973       Impact factor: 23.643

3.  Enzymatic acetylation of aminoglycoside antibiotics by Escherichia coli carrying an R factor.

Authors:  R Benveniste; J Davies
Journal:  Biochemistry       Date:  1971-05-11       Impact factor: 3.162

Review 4.  Bacterial resistance to aminoglycoside antibiotics.

Authors:  J Davies; G D Wright
Journal:  Trends Microbiol       Date:  1997-06       Impact factor: 17.079

5.  Characterization of the chromosomal aminoglycoside 2'-N-acetyltransferase gene from Mycobacterium fortuitum.

Authors:  J A Aínsa; C Martin; B Gicquel; R Gomez-Lus
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

6.  In-vitro synergy between aminoglycosides deployed against Staphylococcus spp. harbouring a 6'-aminoglycoside acetyltransferase, 2"-aminoglycoside phosphotransferase enzyme.

Authors:  E Culebras; J C Perez-Diaz; J Blazquez; R Alonso; F Baquero
Journal:  J Antimicrob Chemother       Date:  1994-04       Impact factor: 5.790

Review 7.  Mycobacterial cell wall: structure and role in natural resistance to antibiotics.

Authors:  V Jarlier; H Nikaido
Journal:  FEMS Microbiol Lett       Date:  1994-10-15       Impact factor: 2.742

8.  Correlation of antibiotic resistance with Vmax/Km ratio of enzymatic modification of aminoglycosides by kanamycin acetyltransferase.

Authors:  K Radika; D B Northrop
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

9.  Does aminoglycoside-acetyltransferase in rapidly growing mycobacteria have a metabolic function in addition to aminoglycoside inactivation?

Authors:  T Udou; Y Mizuguchi; R J Wallace
Journal:  FEMS Microbiol Lett       Date:  1989-01-15       Impact factor: 2.742

10.  Permeability barrier to hydrophilic solutes in Mycobacterium chelonei.

Authors:  V Jarlier; H Nikaido
Journal:  J Bacteriol       Date:  1990-03       Impact factor: 3.490

View more
  9 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

2.  Studying aminoglycoside modification by the acetyltransferase class of resistance-causing enzymes via microarray.

Authors:  Olivia J Barrett; Alexei Pushechnikov; Meilan Wu; Matthew D Disney
Journal:  Carbohydr Res       Date:  2008-08-22       Impact factor: 2.104

3.  Reverse engineering antibiotic sensitivity in a multidrug-resistant Pseudomonas aeruginosa isolate.

Authors:  Julie M Struble; Ryan T Gill
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

4.  Overexpression and characterization of the chromosomal aminoglycoside 2'-N-acetyltransferase of Providencia stuartii.

Authors:  K Franklin; A J Clarke
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

5.  Comparative Study of Eis-like Enzymes from Pathogenic and Nonpathogenic Bacteria.

Authors:  Keith D Green; Rachel E Pricer; Megan N Stewart; Sylvie Garneau-Tsodikova
Journal:  ACS Infect Dis       Date:  2015-05-04       Impact factor: 5.084

Review 6.  New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria.

Authors:  Mohammad J Nasiri; Mehri Haeili; Mona Ghazi; Hossein Goudarzi; Ali Pormohammad; Abbas A Imani Fooladi; Mohammad M Feizabadi
Journal:  Front Microbiol       Date:  2017-04-25       Impact factor: 5.640

7.  Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates.

Authors:  Su-Young Kim; Dae Hun Kim; Seong Mi Moon; Ju Yeun Song; Hee Jae Huh; Nam Yong Lee; Sung Jae Shin; Won-Jung Koh; Byung Woo Jhun
Journal:  Sci Rep       Date:  2021-03-17       Impact factor: 4.379

Review 8.  Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment.

Authors:  Mohsen Heidary; Maryam Shirani; Melika Moradi; Mehdi Goudarzi; Ramin Pouriran; Tayebe Rezaeian; Saeed Khoshnood
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2022-04-14

9.  Mab_3168c, a putative acetyltransferase, enhances adherence, intracellular survival and antimicrobial resistance of Mycobacterium abscessus.

Authors:  Sheng-Hui Tsai; Gwan-Han Shen; Chao-Hsiung Lin; Jiue-Ru Liau; Hsin-Chih Lai; Shiau-Ting Hu
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.